Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
KalVista Pharmaceuticals
KalVista Pharmaceuticals
(KALV)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Sebetralstat
hereditary angioedema types i and ii
,
hereditary angioedemas
,
angioedema
Hyaluronate sodium
eye diseases
,
capsule opacification
,
phacoemulsification
,
cataract
,
dry eye syndromes
,
keratoconjunctivitis sicca
,
syndrome
Nepidermin
multiple sclerosis
,
sclerosis
Telbermin
neoplasms
,
neoplasm metastasis
,
macular edema
,
edema
Bos taurus adrenal cortex corticosteroids
atrophic vaginitis
,
physiological sexual dysfunction
,
psychological sexual dysfunctions
,
breast neoplasms
,
hot flashes
,
dyspareunia
,
menopause
Monovisc
knee osteoarthritis
,
osteoarthritis
Provisc
eye diseases
,
capsule opacification
,
phacoemulsification
,
cataract
,
dry eye syndromes
,
keratoconjunctivitis sicca
,
syndrome
Demand
hemophilia a
Hylan g-f 20
knee osteoarthritis
,
osteoarthritis
Hyalgan
eye diseases
,
capsule opacification
,
phacoemulsification
,
cataract
,
dry eye syndromes
,
keratoconjunctivitis sicca
,
syndrome
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use